Literature DB >> 10955243

Salpingectomy for repeated embryo nonimplantation after in vitro fertilization in patients with severe tubal factor infertility.

H Dechaud1, T Anahory, N Aligier, F Arnal, H Humeau, B Hedon.   

Abstract

PURPOSE: To evaluate the impact of salpingectomy on the rates of embryo implantation and pregnancy in patients with severe, irreversible tubal factor sterility.
METHODS: A retrospective study of patients with repeated failure of in vitro fertilization due to nonimplantation of the embryo. Seventy-two patients with severe and irreversible tubal factor sterility were selected following repeated failure of in vitro fertilization (IVF) due to assumed nonimplantation of the embryo: 35 underwent a salpingectomy before continuing IVF cycles and 37 continued IVF cycles without salpingectomy.
RESULTS: After the first IVF cycle consecutive to diagnosis of embryo nonimplantation, the implantation rate was 10.2% in the salpingectomy group and 6.1% in the group without the procedure (P = 0.5). After all IVF cycles, the rate was, respectively, 6.9% and 4.5% (P = 0.2). Salpingectomy improved the pregnancy rate (PR) per transfer (23.5% vs. 9.9%; P = 0.01). The curves of the cumulative probability of becoming pregnant show that salpingectomy resulted in pregnancy more rapidly.
CONCLUSIONS: Salpingectomy improves the PR per transfer in patients with severe and irreversible tubal factor sterility who have experienced repeated failure of IVF due to embryo nonimplantation. This procedure also reduces the number of IVF attempts needed to obtain pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955243      PMCID: PMC3455472          DOI: 10.1023/a:1009487716328

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  38 in total

Review 1.  Hydrosalpinx affects the implantation of previously cryopreserved embryos.

Authors:  M A Akman; J E Garcia; M D Damewood; L D Watts; E Katz
Journal:  Hum Reprod       Date:  1996-05       Impact factor: 6.918

Review 2.  The infertile patient with hydrosalpinges--IVF with or without salpingectomy?

Authors:  A N Andersen; A Lindhard; A Loft; S Ziebe; C Y Andersen
Journal:  Hum Reprod       Date:  1996-10       Impact factor: 6.918

Review 3.  Salpingectomy improves in-vitro fertilization outcome in patients with a hydrosalpinx: blind victimization of the fallopian tube?

Authors:  P J Puttemans; I A Brosens
Journal:  Hum Reprod       Date:  1996-10       Impact factor: 6.918

4.  Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis: a case for prophylactic salpingectomy.

Authors:  T Mukherjee; A B Copperman; C McCaffrey; C A Cook; M Bustillo; M F Obasaju
Journal:  Fertil Steril       Date:  1996-11       Impact factor: 7.329

Review 5.  [Hydrosalpinx and sterility: indications for salpingectomy].

Authors:  F X Aubriot; C Chapron; P Morice; J B Dubuisson
Journal:  Contracept Fertil Sex       Date:  1995-11

6.  Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx.

Authors:  K E Shelton; L Butler; J P Toner; S Oehninger; S J Muasher
Journal:  Hum Reprod       Date:  1996-03       Impact factor: 6.918

7.  In-vitro fertilization outcome in women with hydrosalpinx.

Authors:  F I Sharara; R T Scott; E L Marut; J T Queenan
Journal:  Hum Reprod       Date:  1996-03       Impact factor: 6.918

8.  High tubal damage grade is associated with low pregnancy rate in women undergoing in-vitro fertilization treatment.

Authors:  G Csemiczky; B M Landgren; G Fried; H Wramsby
Journal:  Hum Reprod       Date:  1996-11       Impact factor: 6.918

9.  Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization.

Authors:  E Katz; M A Akman; M D Damewood; J E García
Journal:  Fertil Steril       Date:  1996-07       Impact factor: 7.329

10.  Prospective study of tubal mucosal lesions and fertility in hydrosalpinges.

Authors:  G Vasquez; W Boeckx; I Brosens
Journal:  Hum Reprod       Date:  1995-05       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.